Retrieve available abstracts of 48 articles: HTML format
Single Articles
September 2025
XUAN Z, Pan Z, Ma C, Lin X, et al Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
Neurology. 2025;105:e210094. PubMed
SCHULZ RS, Rist PM, Kurth T Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
Neurology. 2025;105:e210158. PubMed
GANESH A, Galetta SL Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
Neurology. 2025;105:e214084. PubMed
July 2025
ELLER MT, Schwarzova K, Gufler L, Karisik A, et al CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or
Stroke: A Review.
Neurology. 2025;105:e213852. PubMedAbstract available
June 2025
CAMANNI M, van Gelder MMHJ, Cantarutti A, Nordeng H, et al Association of Prenatal Exposure to Triptans, Alone or Combined With Other
Migraine Medications, and Neurodevelopmental Outcomes in Offspring.
Neurology. 2025;104:e213678. PubMedAbstract available
March 2025
KELLIER D, Anto MM, Hall M, Marin J, et al Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis,
Testing, and Management in Children With Headache.
Neurology. 2025;104:e213351. PubMedAbstract available
SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A
Delphi Study.
Neurology. 2025;104:e210235. PubMedAbstract available
February 2025
HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine:
A Randomized, Double-Blind, Sham-Controlled Trial.
Neurology. 2025;104:e210220. PubMedAbstract available
January 2025
LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al Early Improvements With Atogepant for the Preventive Treatment of Migraine:
Results From 3 Randomized Phase 3 Trials.
Neurology. 2025;104:e210212. PubMedAbstract available
LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy
Syndrome.
Neurology. 2025;104:e210203. PubMed
December 2024
BONNESEN K, Fuglsang CH, Schmidt M Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk
of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
Neurology. 2024;103:e210034. PubMedAbstract available
WANG K, Sico JJ Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer
Choice?
Neurology. 2024;103:e210196. PubMed
November 2024
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication
Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
Neurology. 2024;103:e209868. PubMed
ALLEN C, Rastall DP Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
Neurology. 2024;103:e209957. PubMed
Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The
Population-Based Rotterdam Study.
Neurology. 2024;103:e210022. PubMed
September 2024
KUMAR A, Joshi D, Singh VK Harlequin Syndrome: A Rare Association With Migraine.
Neurology. 2024;103:e209792. PubMed
SCHULZ RS, Glatz T, Buring JE, Rist PM, et al Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
Neurology. 2024;103:e209747. PubMedAbstract available
LIPTON RB, Harriott AM, Ma JY, Smith JH, et al Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the
Migraine Prodrome: Results From the Randomized PRODROME Trial.
Neurology. 2024;103:e209745. PubMedAbstract available
August 2024
AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The
Population-Based Rotterdam Study.
Neurology. 2024;103:e209700. PubMedAbstract available
July 2024
GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication
Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
Neurology. 2024;103:e209584. PubMedAbstract available
May 2024
CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al Differences in Cortical Morphology in People With and Without Migraine: A
Registry for Migraine (REFORM) MRI Study.
Neurology. 2024;102:e209305. PubMedAbstract available
REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom
2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
Neurology. 2024;102:e209349. PubMedAbstract available
April 2024
DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year
After COVID-19 or Influenza Hospitalization.
Neurology. 2024;102:e209248. PubMedAbstract available
VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al Frequency and Clinical Features of Space Headache Experienced by Astronauts
During Long-Haul Space Flights.
Neurology. 2024;102:e209224. PubMedAbstract available
PETROVA M, Besedina O, Hare B, Gupta A, et al Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective
Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005).
Neurology. 2024;102. PubMedAbstract available
BLUMENFELD A, Mechtler L, Cook L, Rhyne C, et al Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of
Chronic Migraine: A Retrospective Chart Review (P4-12.001).
Neurology. 2024;102. PubMedAbstract available
February 2024
LATEEF TM, Dey D, Leroux A, Cui L, et al Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With
Incident Headache in a Community-Based Sample.
Neurology. 2024;102:e208102. PubMedAbstract available
PIZER JH, Aita SL, Myers MA, Hawley NA, et al Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive
Multidomain Meta-Analysis.
Neurology. 2024;102:e208109. PubMedAbstract available
SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden,
and Quality of Life.
Neurology. 2024;102:e208074. PubMedAbstract available
KEMPNER J Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
Neurology. 2024;102:e209192. PubMed
January 2024
HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk
of Premature Myocardial Infarction and Stroke.
Neurology. 2024;102:e207813. PubMedAbstract available
November 2023
CHIANG CC, Fang X, Horvath Z, Cadiou F, et al Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million
Users' Self-Reported Records From a Smartphone Application.
Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964. PubMedAbstract available
FRIEDMAN SA, Robbins MS Millions of Migraine Attacks, Many Answers, More Questions.
Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084. PubMed
August 2023
FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With
Moderate to Severe Migraine.
Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648. PubMedAbstract available
VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for
Migraine in Children and Adolescents.
Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677. PubMedAbstract available
July 2023
VANDERPLUYM JH Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine
Medications: Striving to Compare Apples to Apples.
Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672. PubMed
SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al Variation in Endpoints in FDA Medication Approvals: A Review of Acute and
Preventive Migraine Medications.
Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544. PubMedAbstract available
PONDER M, Wood ME Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
Neurology. 2023;101:53-54. PubMed
June 2023
LIU J, Quan S, Zhao L, Yuan K, et al Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With
Migraine to Select Electroacupuncture Treatments.
Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484. PubMedAbstract available
May 2023
ORNELLO R, Sposato LA, Sacco S Author Response: Microembolism and Other Links Between Migraine and Stroke:
Clinical and Pathophysiologic Update.
Neurology. 2023;100:1033. PubMed
LEWIS A, Galetta S Editors' Note: Microembolism and Other Links Between Migraine and Stroke:
Clinical and Pathophysiologic Update.
Neurology. 2023;100:1032. PubMed
SCUTELNIC A, Jung S, Schankin CJ Reader Response: Microembolism and Other Links Between Migraine and Stroke:
Clinical and Pathophysiologic Update.
Neurology. 2023;100:1032-1033. PubMed
April 2023
KARCESKI S Migraine and Hormones: A Complex Interaction.
Neurology. 2023;100:e1849-e1851. PubMed
BARBANTI P, Aurilia C, Egeo G, Torelli P, et al Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter,
Prospective, Observational Study.
Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292. PubMedAbstract available
Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168. PubMed
March 2023
BENKLI B, Kim SY, Koike N, Han C, et al Circadian Features of Cluster Headache and Migraine: A Systematic Review,
Meta-analysis, and Genetic Analysis.
Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240. PubMedAbstract available
SUTHERLAND H, Griffiths L It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329. PubMed
August 2022
ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic
Intracranial Hypertension: A Population-Based Matched Cohort Study.
Neurology. 2022 Aug 19. pii: WNL.0000000000201064. PubMedAbstract available